Published in Medical Letter on the CDC and FDA, July 11th, 2004
These new products complement Exactech's recent introduction of InterSpace Hip, the first pre-formed antibiotic hip spacer cleared by the FDA for distribution to the U.S. market.
The InterSpace knee spacer is a major advancement in treating patients suffering from the complication of infected total knee arthroplasty. InterSpace Knee allows the patient assisted mobility between the first and second stages in two stage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.